Osterweis Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Osterweis Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-125,190	Closed	-$4.03M	–	112
2019 Q1	$4.03M	Buy	+125,190	New	+$3.87M	0.25%	73
2018 Q4	–	Sell	-7,122	Closed	-$205K	–	122
2018 Q3	$205K	Hold	7,122	–	–	0.01%	109
2018 Q2	$267K	Hold	7,122	–	–	0.02%	101
2018 Q1	$280K	Hold	7,122	–	–	0.02%	100
2017 Q4	$231K	Hold	7,122	–	–	0.02%	98
2017 Q3	$222K	Buy	+7,122	New	+$211K	0.02%	98
2015 Q3	–	Sell	-7,122	Closed	-$204K	–	65
2015 Q2	$204K	Buy	+7,122	New	+$187K	0.01%	62

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Osterweis Capital Management's XENT Position: Q2 2019 in Review

Osterweis Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 125,190 shares — an estimated $4.03M sold.

Osterweis Capital Management first reported a position in XENT in Q2 2015 and held it in 7 quarters. The position peaked at $4.03M in Q1 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

Osterweis Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
Osterweis Capital Management sold 125,190 Intersect ENT, Inc shares in Q2 2019, an estimated $4.03M.
Osterweis Capital Management first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 7 quarters.
Osterweis Capital Management's Intersect ENT, Inc position peaked at $4.03M in Q1 2019.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Osterweis Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.